Stock MUSCLE PHARM CORPORATION.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Other languages Muscle Pharm Corporation. OTC Bulletin Board

Equities

US6273351022

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Muscle Pharm Corporation.
2023 Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation CI
2023 FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q). CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation
FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).
Musclepharm Corporation Announces Resignation of Paul Karr as Director
First Amended Disclosure Statement Approved for MusclePharm Corporation
First Motion for Exclusivity Period Extension Approved For MusclePharm Corporation
MusclePharm Corporation has withdrawn its IPO in the amount of $10 million.
First Motion for Exclusivity Period Extension Filed by MusclePharm Corporation
MusclePharm Corporation Filed for Bankruptcy
MusclePharm Corporation Announces Board Changes
Sabina Rizvi Notifies MusclePharm Corporation of Her Resignation as President, Effective July 22, 2022
MusclePharm Announces the Launch of FitMiss Energy
Musclepharm Corporation Appoints Eric Chin as Chief Accounting Officer
MusclePharm Corporation has filed an IPO in the amount of $10 million.
MusclePharm Corporation Appoints Sabina Rizvi as Member of the Board of Directors
Earnings Flash (MSLP) MUSCLEPHARM CORPORATION Reports Q1 Revenue $13.1M
MusclePharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
MusclePharm Corporation Auditor Raises 'Going Concern' Doubt
Earnings Flash (MSLP) MUSCLEPHARM CORPORATION Posts Q4 Revenue $10M
MusclePharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
MusclePharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2021
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MSLP Stock
  4. Stock
  5. News Muscle Pharm Corporation.
  6. Other languages